Pinta Biotherapeutics, Inc. — Form D
Pinta Biotherapeutics, Inc. of BRISBANE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2013-12-10. The offering totals $18.0M, of which $18.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-12-10
- Form: D
- Accession: 0001019687-13-004770
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $18.0M
- Amount sold: $18.0M
- Investors: 12
- Date of first sale: 2013-11-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-207720
Issuer
- Name: Pinta Biotherapeutics, Inc.
- CIK: 0001593629
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 3260 BAYSHORE BLVD., BRISBANE, CA, 94005
- Phone: 415-287-2411
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Isaac Ciechanover | Director | CAMBRIDGE, MA |
| Isaac Ciechanover | Executive Officer | CAMBRIDGE, MA |
| Carol F Gallagher | Director | San Francisco, CA |
| Christopher F Haqq | Executive Officer | BRISBANE, CA |
| Joel F Marcus | Director | BRISBANE, CA |
| John F McGrath | Executive Officer | BRISBANE, CA |
| Beth F Seidenberg | Director | BRISBANE, CA |
| Gad F Soffer | Executive Officer | BRISBANE, CA |
| Eckard F Weber | Director | Palo Alto, CA |
Other filings by this issuer (1)
More